ArticleNature communications2023

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade.

Crismita Dmello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.